Journal of Cardiovascular Pharmacology and Therapeutics

Papers
(The TQCC of Journal of Cardiovascular Pharmacology and Therapeutics is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
A Comprehensive Review of PCSK9 Inhibitors43
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Di30
The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart27
Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes?22
Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men20
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database20
Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data19
Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways18
Fondaparinux Sodium: Recent Advances in the Management of Thrombosis16
COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges15
The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction14
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial13
Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension13
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study12
Umbrella Review on Non-Statin Lipid-Lowering Therapy12
Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms12
Cardioprotection and its Translation: A Need for New Paradigms? Or for New Pragmatism? An Opinionated Retro- and Perspective11
The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review10
COVID-19: The Heart of the Matter—Pathological Changes and a Proposed Mechanism10
Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation10
Effects of Electronic Cigarette Exposure on Myocardial Infarction and No-Reflow, and Cardiac Function in a Rat Model10
The Prognostic Value of the Triglyceride Glucose Index in Patients With Acute Myocardial Infarction10
Nucleolin Improves Heart Function During Recovery From Myocardial Infarction by Modulating Macrophage Polarization9
Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction9
Testosterone Deficiency, Long-Term Testosterone Therapy, and Inflammation8
GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease8
Repurposing From Oncology to Cardiology: Low-Dose 5-Azacytidine Attenuates Pathological Cardiac Remodeling in Response to Pressure Overload Injury8
Remote Ischemic Perconditioning Ameliorates Myocardial Ischemia and Reperfusion-Induced Coronary Endothelial Dysfunction and Aortic Stiffness in Rats7
Bioassays of Humoral Cardioprotective Factors Released by Remote Ischemic Conditioning in Patients Undergoing Coronary Artery Bypass Surgery7
Atglistatin Pretreatment Preserves Remote Myocardium Function Following Myocardial Infarction7
Left Ventricular Thrombus Therapy With Direct Oral Anticoagulants Versus Vitamin K Antagonists: A Systematic Review and Meta-Analysis7
Gender Related Differences in Gastrointestinal Bleeding With Oral Anticoagulation in Atrial Fibrillation7
0.026530027389526